Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ORGANIZATION
ORGANIZATION
- Generic Switch Saved 22.7 Billion Yen in Drug Costs over 5 Years: Kyokai Kenpo
July 17, 2014
- JGA to Use Independent Organizations to Conduct GMP Inspections of Overseas Drug Substance Production Facilities
July 17, 2014
- Cochrane Collaboration Establishes Japanese Branch; Co-Director Calls for “Full Disclosure” of Clinical Research
July 14, 2014
- Medwatcher Wants Structural Problems of Pharma Industry and Researchers Revealed During Diovan Trials
July 3, 2014
- JMA Exec Matsumoto Tipped to Replace Adachi as Chuikyo Rep
July 3, 2014
- “No Need to Step Down” as Chair of Biz Lobby, Govt Panel Member: Takeda CEO
July 2, 2014
- Yokokura Reelected as JMA President, 3 Incumbents Retain Veep Seats
July 2, 2014
- Research-Driven Pharmas Could Diverge into 2 Groups Based on Dependence on Off-Patent Drugs: FPMAJ Chair
July 1, 2014
- Min-Iren Urges Novartis to Return “Unfair Profits”
June 24, 2014
- JMA President Yokokura to Serve Second Term
June 20, 2014
- Japan Diabetes Group Announces Recommendations on Proper Use of SGLT-2 Inhibitors
June 17, 2014
- Daiichi Sankyo Pres. Nakayama Elected as New President of PMAT
June 17, 2014
- New Price Cut Rule Barring Generic Replacement of Long-Listed Products: FPMAJ
June 17, 2014
- US-Japan Business Council Airs Concerns over Annual NHI Price Revision
June 13, 2014
- Member Companies Conducted 682 Clinical Trials in Japan in 2013: PhRMA/EFPIA
June 11, 2014
- Generic Versions of Combination Drug Exforge to Be Named “Amvalo”: JSGM
June 10, 2014
- Santen President Officially Becomes New OPMA Head
May 29, 2014
- FPMAJ, JPMA Issue Joint Statement Opposing Once-Yearly NHI Price Revision
May 29, 2014
- JPWA Chief Highlights Progress in Single-Product, Single-Price Trading
May 27, 2014
- MTPC, MSD Return to JPMA’s BOD
May 26, 2014
ページ
As many as 47 new drug candidates are expected to win approval or secure NHI price listing in Japan in…
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…